Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-28

Clinical Trial Update: The Effect of Naldemedine on Opioid-induced Bowel Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating naldemedine for opioid-induced bowel dysfunction and constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naldemedine (naldemedine)

Snippet

Sponsor: Asbjørn Mohr Drewes | Conditions: Opioid-Induced Bowel Dysfunction, Constipation | Phase 2 | Status: UNKNOWN